The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
MEK1/2 억제제 ATR-002는 SARS-CoV-2 전파를 효율적으로 차단하고 전염증성 사이토카인/케모카인 반응을 완화합니다
Original Article
[키워드] accelerated
activate
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alleviate
anti-influenza drug
Anti-SARS-CoV-2 Activity
antiviral drug
ATR-002
block
cascade
caused
Cell
Cell culture
cell line
cell lines
clinical trial
clinical trials
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 progression
cultures
Cytokines
death
Disease progression
Drug evaluation
early infection
epithelial
epithelial cell
evaluated
expression
fibrosarcoma
high-risk patient
High-risk patients
hyperinflammation
impair
Infection
inhibitor
kinase
kinases
knockdown
limit
medication
MEK1/2-inhibitor
mitogen
mitogen-activated protein kinase
Novel coronavirus
observé
pandemic
pandemic spread
pathway
powerful tool
Prevent
pro-inflammatory
pro-inflammatory cytokines
Protein
Raf/MEK/ERK
respiratory
response
Safe
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 propagation
selective
severe acute respiratory syndrome Coronavirus
Signaling
specific inhibitor
Spread
supplementary material
Symptom
target
therapeutic intervention
Treatment
upstream
vaccination
virus replication
while
[DOI] 10.1007/s00018-021-04085-1 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1007/s00018-021-04085-1 PMC 바로가기 [Article Type] Original Article